Business Description
Navicare Biotech Co Ltd
ISIN : TW0008472002
Description
Navicare Biotech Co Ltd, formerly Gomaji Corp Ltd is a local e-commerce company. The company connects merchants to consumers by offering goods and services at a discount.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.7 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.21 | |||||
Debt-to-EBITDA | 115.88 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.27 | |||||
Beneish M-Score | -1.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13 | |||||
3-Year EPS without NRI Growth Rate | 21.8 | |||||
3-Year FCF Growth Rate | 79.5 | |||||
3-Year Book Growth Rate | -13.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.59 | |||||
9-Day RSI | 41.19 | |||||
14-Day RSI | 44.46 | |||||
3-1 Month Momentum % | 12.43 | |||||
6-1 Month Momentum % | 25.37 | |||||
12-1 Month Momentum % | 105.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.68 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 53.97 | |||||
Days Sales Outstanding | 51.63 | |||||
Days Payable | 294.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -3.92 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.48 | |||||
Operating Margin % | -6.59 | |||||
Net Margin % | -5.06 | |||||
EBITDA Margin % | 0.6 | |||||
FCF Margin % | -0.69 | |||||
OCF Margin % | -0.67 | |||||
ROE % | -8.82 | |||||
ROA % | -2.36 | |||||
ROIC % | -3.23 | |||||
3-Year ROIIC % | -28.72 | |||||
ROC (Joel Greenblatt) % | -4.82 | |||||
ROCE % | -2.92 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.95 | |||||
PB Ratio | 5.19 | |||||
Price-to-Tangible-Book | 5.28 | |||||
EV-to-EBIT | -110.92 | |||||
EV-to-EBITDA | 545.86 | |||||
EV-to-Revenue | 3.26 | |||||
EV-to-FCF | -465.36 | |||||
Price-to-GF-Value | 1.79 | |||||
Price-to-Median-PS-Value | 1.91 | |||||
Earnings Yield (Greenblatt) % | -0.9 | |||||
FCF Yield % | -0.22 | |||||
Forward Rate of Return (Yacktman) % | -0.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Navicare Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 473.618 | ||
| EPS (TTM) (NT$) | -1.35 | ||
| Beta | 0.2359 | ||
| 3-Year Sharpe Ratio | 0.53 | ||
| 3-Year Sortino Ratio | 1.71 | ||
| Volatility % | 117.25 | ||
| 14-Day RSI | 44.46 | ||
| 14-Day ATR (NT$) | 3.777672 | ||
| 20-Day SMA (NT$) | 82.06 | ||
| 12-1 Month Momentum % | 105.56 | ||
| 52-Week Range (NT$) | 45.4 - 106.5 | ||
| Shares Outstanding (Mil) | 17.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Navicare Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Navicare Biotech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Navicare Biotech Co Ltd Frequently Asked Questions
What is Navicare Biotech Co Ltd(ROCO:8472)'s stock price today?
The current price of ROCO:8472 is NT$79.00. The 52 week high of ROCO:8472 is NT$106.50 and 52 week low is NT$45.40.
When is next earnings date of Navicare Biotech Co Ltd(ROCO:8472)?
The next earnings date of Navicare Biotech Co Ltd(ROCO:8472) is .
Does Navicare Biotech Co Ltd(ROCO:8472) pay dividends? If so, how much?
Navicare Biotech Co Ltd(ROCO:8472) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Navicare Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers